Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

BioXcel Therapeutics, Inc. (BTAIQ) vs PainReform Ltd. (PRFX)

BioXcel Therapeutics, Inc. and PainReform Ltd. are both Drug Manufacturers Specialty & Generic companies. PainReform Ltd. is the larger, with a market value of $3.0M against $2.3M — 1.3× the size. PainReform Ltd. has the higher net margin (0.00% vs −9,549.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, BioXcel Therapeutics, Inc. leads on 6 and PainReform Ltd. on 6.

Valuation

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.63 n/m 2.25
P/B n/m 0.00 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.99 12.29
EV/Sales 228.73 n/m 2.56
Earnings yield (9,475.00%) (61,696.04%) (2.99%)
Free cash flow yield (4,201.65%) (80,633.63%) 0.00%

Profitability

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
Gross margin 53.10% 0.00% 53.94%
Operating margin (6,054.72%) 0.00% 0.00%
Net margin (9,549.87%) 0.00% 0.00%
Free cash flow margin (6,860.38%) 0.00% 0.00%
Return on equity 63.52% 0.00% (0.40%)
Return on assets (259.62%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (14.52%) — 10.01%
EPS growth (last fiscal year) 75.63% 92.92% —
Revenue growth, 5-year CAGR — — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.00 0.05
Current ratio 0.21 5.07 2.31
Net debt to EBITDA (1.61) 0.96 0.85

Dividend

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric BTAIQ PRFX Drug Manufacturers Specialty & Generic median
Market cap 2.31m 2.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack